Follow
Nagi El Saghir
Nagi El Saghir
Professor of Clinical Medicine, American University of Beirut
Verified email at aub.edu.lb - Homepage
Title
Cited by
Cited by
Year
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
12242018
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ...
Annals of Oncology 31 (12), 1623-1649, 2020
10202020
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ...
The lancet oncology 19 (7), 904-915, 2018
8922018
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
8742017
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
The Breast 23 (5), 489-502, 2014
8362014
Epidemiology and prognosis of breast cancer in young women
HA Assi, KE Khoury, H Dbouk, LE Khalil, TH Mouhieddine, NS El Saghir
Journal of thoracic disease 5 (Suppl 1), S2, 2013
5072013
Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis
NS El Saghir, MK Khalil, T Eid, AR El Kinge, M Charafeddine, F Geara, ...
International journal of surgery 5 (4), 225-233, 2007
4422007
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, D Cameron, T Cufer, L Fallowfield, ...
The Breast 21 (3), 242-252, 2012
4052012
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
BO Anderson, E Cazap, NS El Saghir, CH Yip, HM Khaled, IV Otero, ...
The lancet oncology 12 (4), 387-398, 2011
3882011
Effects of young age at presentation on survival in breast cancer
NS El Saghir, M Seoud, MK Khalil, M Charafeddine, ZK Salem, FB Geara, ...
BMC cancer 6, 1-8, 2006
3752006
Overview, prevention and management of chemotherapy extravasation
FY Kreidieh, HA Moukadem, NS El Saghir
World journal of clinical oncology 7 (1), 87, 2016
2302016
Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide
NS El Saghir, NL Keating, RW Carlson, KE Khoury, L Fallowfield
American Society of Clinical Oncology Educational Book 34 (1), e461-e466, 2014
2242014
Cancer epidemiology and control in the arab world-past, present and future
EI Salim, MA Moore, JA Al-Lawati, J Al-Sayyad, A Bazawir, A Bener, ...
Asian Pac J Cancer Prev 10 (1), 3-16, 2009
2142009
Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative
NS El Saghir, CA Adebamowo, BO Anderson, RW Carlson, PA Bird, ...
The Breast 20, S3-S11, 2011
2122011
Enhancing global access to cancer medicines
J Cortes, JM Perez‐García, A Llombart‐Cussac, G Curigliano, ...
CA: a cancer journal for clinicians 70 (2), 105-124, 2020
1622020
Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 …
PA Ganz, CH Yip, JR Gralow, SR Distelhorst, KS Albain, BL Andersen, ...
The Breast 22 (5), 606-615, 2013
1482013
Breast cancer treatment: A phased approach to implementation
M Mutebi, BO Anderson, C Duggan, C Adebamowo, G Agarwal, Z Ali, ...
Cancer 126, 2365-2378, 2020
1442020
ESMO/ASCO recommendations for a global curriculum in medical oncology edition 2016
C Dittrich, M Kosty, S Jezdic, D Pyle, R Berardi, J Bergh, N El-Saghir, ...
ESMO open 1 (5), e000097, 2016
1332016
Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the “do ut des” paradigm)
G de Castro Junior, F Puglisi, E de Azambuja, NS El Saghir, A Awada
Critical reviews in oncology/hematology 59 (1), 40-50, 2006
1262006
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2 Advanced …
YS Lu, SA Im, M Colleoni, F Franke, A Bardia, F Cardoso, N Harbeck, ...
Clinical Cancer Research 28 (5), 851-859, 2022
1172022
The system can't perform the operation now. Try again later.
Articles 1–20